Literature DB >> 10790219

Mutation analysis in 36 unrelated Spanish subjects with familial hypercholesterolemia: identification of 3 novel mutations in the LDL receptor gene.

P Mozas1, A Cenarro, F Civeira, S Castillo, E Ros, M Pocovi.   

Abstract

We used the single strand conformation polymorphism (SSCP) method to investigate 36 apparently unrelated Spanish patients with familial hypercholesterolemia (FH) for mutations in the promoter region and the 18 exons and their flanking intron sequences of the low density lipoprotein receptor (LDLR) gene. Nineteen aberrant SSCP patterns were found, and the underlying mutations were characterized by DNA sequencing. In addition, we tested all patients for the presence of mutations in the gene coding for apolipoprotein B (apo B). Five missense mutations (Q71E, S156L, E256K, N543H and T705I), four nonsense mutations (W(-18)X, E10X, Q133X and C255X), six frameshift mutations (211delG, 518delG, 1045delC, 2085del19, 2207insT and 2393del9) and five splicing mutations (313+1G->C, 1061-8T->C, 1845+1G->C, 2140+5G->A and 2390-1G->C) were identified in the LDLR gene. In total, we detected 20 mutations, 3 of which, designated 1045delC, 1845+1G->C and 2207insT, have not been previously described. Seven patients were found to carry two different mutations in the same allele: W(-18)X and E256K (one patient), Q71E and 313+1G->C (two patients), 1061-8T->C and T705I (two patients), 518delG and 2140+5G->A (one patient) and N543H and 2393del9 (one patient). As we expected, there is a broad spectrum of mutations in the LDLR gene, given the genetic heterogeneity of the Spanish population. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790219     DOI: 10.1002/(SICI)1098-1004(200005)15:5<483::AID-HUMU19>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  6 in total

1.  Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction.

Authors:  Ingrid Brænne; Mariana Kleinecke; Benedikt Reiz; Elisabeth Graf; Tim Strom; Thomas Wieland; Marcus Fischer; Thorsten Kessler; Christian Hengstenberg; Thomas Meitinger; Jeanette Erdmann; Heribert Schunkert
Journal:  Eur J Hum Genet       Date:  2015-06-03       Impact factor: 4.246

2.  Haplotype analyses, mechanism and evolution of common double mutants in the human LDL receptor gene.

Authors:  M T Tejedor; A Cenarro; D Tejedor; M Stef; R Mateo-Gallego; I de Castro; A L García-Otin; L V Monteagudo; F Civeira; M Pocovi
Journal:  Mol Genet Genomics       Date:  2010-04-29       Impact factor: 3.291

3.  Familial hypercholesterolemia in St-Petersburg: the known and novel mutations found in the low density lipoprotein receptor gene in Russia.

Authors:  Faina M Zakharova; Dorte Damgaard; Michail Y Mandelshtam; Valery I Golubkov; Peter H Nissen; Gitte G Nilsen; Anette Stenderup; Boris M Lipovetsky; Vladimir O Konstantinov; Alexander D Denisenko; Vadim B Vasilyev; Ole Faergeman
Journal:  BMC Med Genet       Date:  2005-02-08       Impact factor: 2.103

4.  Heterozygous familial hypercholesterolaemia in a pair of identical twins: a case report and updated review.

Authors:  Noor Shafina Mohd Nor; Alyaa Mahmood Al-Khateeb; Yung-An Chua; Noor Alicezah Mohd Kasim; Hapizah Mohd Nawawi
Journal:  BMC Pediatr       Date:  2019-04-11       Impact factor: 2.125

5.  Mutation scanning by meltMADGE: validations using BRCA1 and LDLR, and demonstration of the potential to identify severe, moderate, silent, rare, and paucimorphic mutations in the general population.

Authors:  Khalid K Alharbi; Mohammed A Aldahmesh; Emmanuel Spanakis; Lema Haddad; Roslyn A Whittall; Xiao-he Chen; Hamid Rassoulian; Matt J Smith; Julie Sillibourne; Nicola J Ball; Nikki J Graham; Patricia J Briggs; Iain A Simpson; David I W Phillips; Deborah A Lawlor; Shu Ye; Stephen E Humphries; Cyrus Cooper; George Davey Smith; Shah Ebrahim; Diana M Eccles; Ian N M Day
Journal:  Genome Res       Date:  2005-07       Impact factor: 9.043

6.  Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations.

Authors:  Marta Futema; Vincent Plagnol; KaWah Li; Ros A Whittall; H Andrew W Neil; Mary Seed; Stefano Bertolini; Sebastiano Calandra; Olivier S Descamps; Colin A Graham; Robert A Hegele; Fredrik Karpe; Ronen Durst; Eran Leitersdorf; Nicholas Lench; Devaki R Nair; Handrean Soran; Frank M Van Bockxmeer; Steve E Humphries
Journal:  J Med Genet       Date:  2014-07-01       Impact factor: 6.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.